Page last updated: 2024-09-05

pi 083 and pyrazines

pi 083 has been researched along with pyrazines in 2 studies

*Pyrazines: A heterocyclic aromatic organic compound with the chemical formula C4H4N2. [MeSH]

Compound Research Comparison

Studies (pi 083)	Trials (pi 083)	Recent Studies (post-2010) (pi 083)	Studies (pyrazines)	Trials (pyrazines)	Recent Studies (post-2010) (pyrazines)
5	0	1	12,165	1,373	5,747

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berndt, N; Guida, WC; Kazi, A; Lawrence, H; McLaughlin, ML; Sebti, SM; Springett, GM; Yip, RM	1
Grant, S	1

Other Studies

2 other study(ies) available for pi 083 and pyrazines

Article	Year
Discovery of a novel proteasome inhibitor selective for cancer cells over non-transformed cells. Cell cycle (Georgetown, Tex.), 2009, Jun-15, Volume: 8, Issue:12 Topics: Animals; Anthracyclines; Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chymotrypsin; Cyclin-Dependent Kinase Inhibitor p27; Drug Discovery; Humans; Inhibitory Concentration 50; Intracellular Signaling Peptides and Proteins; Mice; Mice, Nude; Neoplasms; Proteasome Inhibitors; Protein Conformation; Pyrazines; Serine Proteinase Inhibitors; Small Molecule Libraries; Xenograft Model Antitumor Assays	2009
Selectively killing transformed cells through proteasome inhibition. Cell cycle (Georgetown, Tex.), 2009, Oct-01, Volume: 8, Issue:19 Topics: Anthracyclines; Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Transformation, Neoplastic; Humans; Neoplasms; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Ubiquitination	2009

Article

Year

Discovery of a novel proteasome inhibitor selective for cancer cells over non-transformed cells.

Cell cycle (Georgetown, Tex.), 2009, Jun-15, Volume: 8, Issue:12

Topics: Animals; Anthracyclines; Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chymotrypsin; Cyclin-Dependent Kinase Inhibitor p27; Drug Discovery; Humans; Inhibitory Concentration 50; Intracellular Signaling Peptides and Proteins; Mice; Mice, Nude; Neoplasms; Proteasome Inhibitors; Protein Conformation; Pyrazines; Serine Proteinase Inhibitors; Small Molecule Libraries; Xenograft Model Antitumor Assays

2009

Selectively killing transformed cells through proteasome inhibition.

Cell cycle (Georgetown, Tex.), 2009, Oct-01, Volume: 8, Issue:19

Topics: Anthracyclines; Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Transformation, Neoplastic; Humans; Neoplasms; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Ubiquitination

2009